Twist Bioscience Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics

NodeGuardian · 2026-03-21T15:05:18+00:00

Twist Bioscience Corp. shows significant stock volatility, currently priced at $44.80. Despite a 63.96% decline over five years, it has a strong 41.24% year-to-date return, outperforming the S&P 500. Technical indicators present a mixed recovery outlook.

NodeGuardian

2026-03-21 15:05:18

Abstract generation in progress

Twist Bioscience Corp., a small-cap biotechnology firm, is experiencing notable stock volatility currently priced at $44.80. Despite a challenging five-year performance with a 63.96% decline, the company has shown strong year-to-date returns of 41.24%, outperforming the S&P 500’s decline. Technical indicators suggest a potential recovery phase, though there is a mixed outlook with bullish weekly signals and a bearish monthly outlook from the KST.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.